Gene: WWC3
Official Full Name: WWC family member 3provided by HGNC
Gene Summary: This gene encodes a member of the WWC family of proteins, which also includes the WWC1 (KIBRA) gene product and the WWC2 gene product. The protein encoded by this gene includes a C2 domain, which is known to mediate homodimerization in the related WWC1 gene product. [provided by RefSeq, Sep 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12575 | WWC3 Knockout cell line (HeLa) | Human | WWC3 | 1:3~1:6 | Negative | Online Inquiry |
KO12576 | WWC3 Knockout cell line (HCT 116) | Human | WWC3 | 1:2~1:4 | Negative | Online Inquiry |
KO12577 | WWC3 Knockout cell line (HEK293) | Human | WWC3 | 1:3~1:6 | Negative | Online Inquiry |
KO12578 | WWC3 Knockout cell line (A549) | Human | WWC3 | 1:3~1:4 | Negative | Online Inquiry |
WWC3 Gene Knockout Cell Lines are specialized cellular models engineered to lack the WWC3 gene, a key regulator implicated in diverse cellular processes, including cell proliferation, differentiation, and apoptosis. By employing CRISPR-Cas9 genome editing technology, these knockout cell lines provide a valuable tool for researchers seeking to dissect the cellular and molecular ramifications of WWC3 depletion within various biological contexts.
The primary function of WWC3 Gene Knockout Cell Lines is to facilitate in vivo and in vitro studies that aim to elucidate the role of WWC3 in signaling pathways and disease mechanisms. These cell lines allow for the exploration of WWC3's involvement in disease states such as cancer, as well as its impact on cellular responses to environmental stresses. This capability is crucial for understanding the gene's functional biology and can lead to the development of novel therapeutic strategies.
From a scientific standpoint, the availability of these knockout cell lines is transformative for both research and clinical applications. They enable researchers to unravel complex biological interactions and validate the functional roles of specific genes in model systems. In clinical settings, such insights can guide the identification of biomarkers and therapeutic targets, making WWC3 Gene Knockout Cell Lines indispensable for translational research.
What sets these knockout cell lines apart from alternatives is the precision and efficiency offered by the CRISPR-Cas9 editing system, ensuring reproducible and reliable gene deletion. Additionally, our cell lines are readily available and validated for consistent performance, streamlining the research process, and expediting experimental timelines.
This product is invaluable for researchers and clinicians who seek to advance their understanding of gene function and its implications in disease. Furthermore, our extensive experience in the field of genetic engineering and commitment to providing high-quality biological products empowers our clients to conduct groundbreaking research with confidence.
Our company prides itself on harnessing cutting-edge technology to deliver solutions that meet the evolving needs of the scientific community, ensuring our clients have access to the best resources for their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.